275 related articles for article (PubMed ID: 18706659)
1. Therapeutic targeting of chemokine signaling in Multiple Sclerosis.
Hamann I; Zipp F; Infante-Duarte C
J Neurol Sci; 2008 Nov; 274(1-2):31-8. PubMed ID: 18706659
[TBL] [Abstract][Full Text] [Related]
2. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
Correale J; Villa A
Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
[TBL] [Abstract][Full Text] [Related]
3. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
[TBL] [Abstract][Full Text] [Related]
4. The expression and function of chemokines involved in CNS inflammation.
Ubogu EE; Cossoy MB; Ransohoff RM
Trends Pharmacol Sci; 2006 Jan; 27(1):48-55. PubMed ID: 16310865
[TBL] [Abstract][Full Text] [Related]
5. Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies.
Szczuciński A; Losy J
Acta Neurol Scand; 2007 Mar; 115(3):137-46. PubMed ID: 17295707
[TBL] [Abstract][Full Text] [Related]
6. Targeting the chemokine system for multiple sclerosis treatment.
Glabinsk AR; Ransohoff RM
Curr Opin Investig Drugs; 2001 Dec; 2(12):1712-9. PubMed ID: 11892933
[TBL] [Abstract][Full Text] [Related]
7. The chemokine system in neuroinflammation: an update.
Ransohoff RM
J Infect Dis; 2002 Dec; 186 Suppl 2():S152-6. PubMed ID: 12424691
[TBL] [Abstract][Full Text] [Related]
8. Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation.
Ubogu EE; Callahan MK; Tucky BH; Ransohoff RM
J Neuroimmunol; 2006 Oct; 179(1-2):132-44. PubMed ID: 16857269
[TBL] [Abstract][Full Text] [Related]
9. Molecular targets for disrupting leukocyte trafficking during multiple sclerosis.
McCandless EE; Klein RS
Expert Rev Mol Med; 2007 Jul; 9(20):1-19. PubMed ID: 17637110
[TBL] [Abstract][Full Text] [Related]
10. Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details.
Rebenko-Moll NM; Liu L; Cardona A; Ransohoff RM
Curr Opin Immunol; 2006 Dec; 18(6):683-9. PubMed ID: 17010588
[TBL] [Abstract][Full Text] [Related]
11. Chemokine network in multiple sclerosis: role in pathogenesis and targeting for future treatments.
Galimberti D; Bresolin N; Scarpini E
Expert Rev Neurother; 2004 May; 4(3):439-53. PubMed ID: 15853541
[TBL] [Abstract][Full Text] [Related]
12. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
[TBL] [Abstract][Full Text] [Related]
13. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases.
Cartier L; Hartley O; Dubois-Dauphin M; Krause KH
Brain Res Brain Res Rev; 2005 Feb; 48(1):16-42. PubMed ID: 15708626
[TBL] [Abstract][Full Text] [Related]
14. Blockade of chemokine signaling in patients with multiple sclerosis.
Zipp F; Hartung HP; Hillert J; Schimrigk S; Trebst C; Stangel M; Infante-Duarte C; Jakobs P; Wolf C; Sandbrink R; Pohl C; Filippi M;
Neurology; 2006 Nov; 67(10):1880-3. PubMed ID: 17130431
[TBL] [Abstract][Full Text] [Related]
15. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.
Alvarez JI; Dodelet-Devillers A; Kebir H; Ifergan I; Fabre PJ; Terouz S; Sabbagh M; Wosik K; Bourbonnière L; Bernard M; van Horssen J; de Vries HE; Charron F; Prat A
Science; 2011 Dec; 334(6063):1727-31. PubMed ID: 22144466
[TBL] [Abstract][Full Text] [Related]
16. Autoantigen signalling through chemokine receptors.
Howard OZ
Curr Opin Rheumatol; 2006 Nov; 18(6):642-6. PubMed ID: 17053513
[TBL] [Abstract][Full Text] [Related]
17. How do immune cells overcome the blood-brain barrier in multiple sclerosis?
Larochelle C; Alvarez JI; Prat A
FEBS Lett; 2011 Dec; 585(23):3770-80. PubMed ID: 21550344
[TBL] [Abstract][Full Text] [Related]
18. Chemokine signaling and integrin activation in lymphocyte migration into the inflamed brain.
Constantin G
J Neuroimmunol; 2008 Jul; 198(1-2):20-6. PubMed ID: 18534690
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Targeting of Chemokines and Chemokine Receptors in Multiple Sclerosis: Opportunities and Challenges.
Sadeghian-Rizi T; Khanahmad H; Jahanian-Najafabadi A
CNS Neurol Disord Drug Targets; 2018; 17(7):496-508. PubMed ID: 30003862
[TBL] [Abstract][Full Text] [Related]
20. [Intercellular adhesion molecules and chemotaxic factors in the pathogenesis of multiple sclerosis].
González-Amaro R; Sánchez-Madrid F
Rev Neurol; 2002 Nov 16-30; 35(10):985-93. PubMed ID: 12436404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
